351 related articles for article (PubMed ID: 30192506)
1. Tissue Plasminogen Activator-Porous Magnetic Microrods for Targeted Thrombolytic Therapy after Ischemic Stroke.
Hu J; Huang S; Zhu L; Huang W; Zhao Y; Jin K; ZhuGe Q
ACS Appl Mater Interfaces; 2018 Oct; 10(39):32988-32997. PubMed ID: 30192506
[TBL] [Abstract][Full Text] [Related]
2. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
[TBL] [Abstract][Full Text] [Related]
3. Rescue localized intra-arterial thrombolysis for hyperacute MCA ischemic stroke patients after early non-responsive intravenous tissue plasminogen activator therapy.
Kim DJ; Kim DI; Kim SH; Lee KY; Heo JH; Han SW
Neuroradiology; 2005 Aug; 47(8):616-21. PubMed ID: 15983773
[TBL] [Abstract][Full Text] [Related]
4. Tissue plasminogen activator-based nanothrombolysis for ischemic stroke.
Liu S; Feng X; Jin R; Li G
Expert Opin Drug Deliv; 2018 Feb; 15(2):173-184. PubMed ID: 28944694
[TBL] [Abstract][Full Text] [Related]
5. Recent advances in targeted delivery of tissue plasminogen activator for enhanced thrombolysis in ischaemic stroke.
Zamanlu M; Farhoudi M; Eskandani M; Mahmoudi J; Barar J; Rafi M; Omidi Y
J Drug Target; 2018 Feb; 26(2):95-109. PubMed ID: 28796540
[TBL] [Abstract][Full Text] [Related]
6. [Recent progress in developing of thrombolytic agents for ischemic stroke].
Xu Y; Chen S; Chen D; Peng S; Cheng Y; Li J; Li Y; Jiang L; Yuan C; Huang M
Sheng Wu Gong Cheng Xue Bao; 2020 Oct; 36(10):2029-2039. PubMed ID: 33169568
[TBL] [Abstract][Full Text] [Related]
7. Intra-arterial administration of microbubbles and continuous 2-MHz ultrasound insonation to enhance intra-arterial thrombolysis.
Ribo M; Molina CA; Alvarez B; Rubiera M; Alvarez-Sabin J; Matas M
J Neuroimaging; 2010 Jul; 20(3):224-7. PubMed ID: 19226340
[TBL] [Abstract][Full Text] [Related]
8. Intravenously administered tissue plasminogen activator useful in milder strokes? A meta-analysis.
Yeo LLL; Ho R; Paliwal P; Rathakrishnan R; Sharma VK
J Stroke Cerebrovasc Dis; 2014 Sep; 23(8):2156-2162. PubMed ID: 25113080
[TBL] [Abstract][Full Text] [Related]
9. Intravenous Thrombolysis Increases the Rate of Dramatic Recovery in Patients with Acute Stroke with an Unknown Onset Time and Negative FLAIR MRI.
Aoki J; Sakamoto Y; Kimura K
J Neuroimaging; 2016 Jul; 26(4):414-9. PubMed ID: 27388586
[TBL] [Abstract][Full Text] [Related]
10. New thrombolytic strategy providing neuroprotection in experimental ischemic stroke: MMP10 alone or in combination with tissue-type plasminogen activator.
Roncal C; Martinez de Lizarrondo S; Salicio A; Chevilley A; Rodriguez JA; Rosell A; Couraud PO; Weksler B; Montaner J; Vivien D; Páramo JA; Orbe J
Cardiovasc Res; 2017 Aug; 113(10):1219-1229. PubMed ID: 28379489
[TBL] [Abstract][Full Text] [Related]
11. Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.
Higashida RT; Furlan AJ; Roberts H; Tomsick T; Connors B; Barr J; Dillon W; Warach S; Broderick J; Tilley B; Sacks D; ;
Stroke; 2003 Aug; 34(8):e109-37. PubMed ID: 12869717
[TBL] [Abstract][Full Text] [Related]
12. The iScore predicts effectiveness of thrombolytic therapy for acute ischemic stroke.
Saposnik G; Fang J; Kapral MK; Tu JV; Mamdani M; Austin P; Johnston SC; ;
Stroke; 2012 May; 43(5):1315-22. PubMed ID: 22308252
[TBL] [Abstract][Full Text] [Related]
13. Equivocal roles of tissue-type plasminogen activator in stroke-induced injury.
Benchenane K; López-Atalaya JP; Fernández-Monreal M; Touzani O; Vivien D
Trends Neurosci; 2004 Mar; 27(3):155-60. PubMed ID: 15036881
[TBL] [Abstract][Full Text] [Related]
14. A multicenter, randomized, controlled study to investigate EXtending the time for Thrombolysis in Emergency Neurological Deficits with Intra-Arterial therapy (EXTEND-IA).
Campbell BC; Mitchell PJ; Yan B; Parsons MW; Christensen S; Churilov L; Dowling RJ; Dewey H; Brooks M; Miteff F; Levi C; Krause M; Harrington TJ; Faulder KC; Steinfort BS; Kleinig T; Scroop R; Chryssidis S; Barber A; Hope A; Moriarty M; McGuinness B; Wong AA; Coulthard A; Wijeratne T; Lee A; Jannes J; Leyden J; Phan TG; Chong W; Holt ME; Chandra RV; Bladin CF; Badve M; Rice H; de Villiers L; Ma H; Desmond PM; Donnan GA; Davis SM;
Int J Stroke; 2014 Jan; 9(1):126-32. PubMed ID: 24207098
[TBL] [Abstract][Full Text] [Related]
15. Dodecafluoropentane Emulsion Extends Window for tPA Therapy in a Rabbit Stroke Model.
Culp WC; Brown AT; Lowery JD; Arthur MC; Roberson PK; Skinner RD
Mol Neurobiol; 2015 Oct; 52(2):979-84. PubMed ID: 26055229
[TBL] [Abstract][Full Text] [Related]
16. Inhibiting 12/15-lipoxygenase to treat acute stroke in permanent and tPA induced thrombolysis models.
Karatas H; Eun Jung J; Lo EH; van Leyen K
Brain Res; 2018 Jan; 1678():123-128. PubMed ID: 29079502
[TBL] [Abstract][Full Text] [Related]
17. Metal ion chelation enhances tissue plasminogen activator (tPA)-induced thrombolysis: an in vitro and in vivo study.
Yu X; Wang Z; Li YV
J Thromb Thrombolysis; 2022 Feb; 53(2):291-301. PubMed ID: 34757546
[TBL] [Abstract][Full Text] [Related]
18. Predictors of early arterial reocclusion after tissue plasminogen activator-induced recanalization in acute ischemic stroke.
Rubiera M; Alvarez-Sabín J; Ribo M; Montaner J; Santamarina E; Arenillas JF; Huertas R; Delgado P; Purroy F; Molina CA
Stroke; 2005 Jul; 36(7):1452-6. PubMed ID: 15947260
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of PI3Kγ by AS605240 plus low-dose tissue plasminogen activator (tPA) combination improves thrombolytic therapy in a rat model of embolic stroke.
Jin R; Zhong W; Liu S; Wang M; Li G
Neurosci Lett; 2020 Nov; 738():135339. PubMed ID: 32882317
[TBL] [Abstract][Full Text] [Related]
20. How can we improve stroke thrombolysis rates? A review of health system factors and approaches associated with thrombolysis administration rates in acute stroke care.
Paul CL; Ryan A; Rose S; Attia JR; Kerr E; Koller C; Levi CR
Implement Sci; 2016 Apr; 11():51. PubMed ID: 27059183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
